Search Results - "Zolcsák, Zita"

Adjuvant Trastuzumab Emtansine (T-DM1) and Concurrent Radiotherapy for Residual Invasive HER2-positive Breast Cancer: Single-center Preliminary Results by Zolcsák, Zita, Loirat, Delphine, Fourquet, Alain, Kirova, Youlia M.

“…The treatment of nonmetastatic HER2-positive breast cancer with residual invasive disease using concurrent Trastuzumab emtansine (T-DM1) and radiotherapy…”
Get full text

Abstract P3-19-24: Long-term follow-up results of intensity modulated radiotherapy in early-stage breast cancer patients by Zolcsák, Zita, Loap, Pierre, Fourquet, Alain, Henry, Alexandre Arsene, Landherr, László, Hamar, Péter, Kirova, Youlia

“…Abstract Introduction: Early breast cancer patients with complex anatomy received adjuvant intensity modulated radiotherapy with helical tomotherapy (IMRT-HT)…”
Get full text

Modulated electro‐hyperthermia suppresses H19, a tumor promoting long non coding RNA, in a triple‐negative breast cancer model by Danics, Lea, Schvarcz, Csaba András, Zolcsák, Zita, Benyó, Zoltán, Kaucsár, Tamás, Hamar, Péter

“…Abstract only Introduction Modulated electro‐hyperthermia (mEHT) is a complementary antitumor therapy, based on selective tumor cell killing by a 13.56 MHz…”
Get full text

Modulated electro hyperthermia inhibits tumor progression in a triple negative mouse breast cancer model by Hamar, Péter, Danics, Lea, Schvarcz, Csaba, Zolcsák, Zita, Benyó, Zoltán, Kaucsár, Tamás

“…Introduction The effective therapy of triple‐negative breast cancer (TNBC) has not yet been achieved. Modulated electro‐hyperthermia (mEHT) is a novel adjuvant…”
Get full text

Multicentric Hungarian results of cabozantinib therapy in patients with metastatic kidney cancer based on real-world data by Maráz, Anikó, Nagyiványi, Krisztián, Balogh, Ingrid, Bodoky, György, Mangel, László, Küronya, Zsófia, Géczi, Lajos, Torday, László, Dudás, Szilvia, Szűcs, Miklós, Nagy, Zsófia, Hornyák, Lajos, Zolcsák, Zita, Bassam, Ali, Kocsis, Judit, Keresztes, Tamás, Kullmann, Tamás, Máhr, Károly, Solymosi, Tibor, Papdán, Tímea, Szabó, Imre, Varga, Zoltán, Biró, Krisztina

“…The aim of our analysis was to evaluate the efficacy of cabozantinib in patients with metastatic renal cell carcinoma. Cabozantinib therapy initiated between…”
Get more information

Multicentric Hungarian results of cabozantinib therapy in patients with metastatic kidney cancer based on real-world data by Maráz, Anikó, Nagyiványi, Krisztián, Balogh, Ingrid, Bodoky, György, Mangel, László, Küronya, Zsófia, Géczi, Lajos, Torday, László, Dudás, Szilvia, Szűcs, Miklós, Nagy, Zsófia, Hornyák, Lajos, Zolcsák, Zita, Bassam, Ali, Kocsis, Judit, Keresztes, Tamás, Kullmann, Tamás, Máhr, Károly, Solymosi, Tibor, Papdán, Tímea, Szabó, Imre, Varga, Zoltán, Biró, Krisztina

“…The aim of our analysis was to evaluate the efficacy of cabozantinib in patients with metastatic renal cell carcinoma. Cabozantinib therapy initiated between…”
Get more information

Preclinical and clinical investigation and development of electromagnetic oncological device - experience with solid tumors by Dank, Magdolna, Balogh, Andrea, Benedek, Anett, Besztercei, Balázs, Danics, Lea, Forika, Gertrud, Garay, Tamás, Hamar, Péter, Karászi, Ádám, Kaucsár, Tamás, Kiss, Éva, Krenács, Tibor, Major, Enikõ, Mohácsi, Réka, Portörõ, István, Ruisanchez, Éva, Schvarcz, Csaba, Szász, Marcell A, Mbuotidem, Thomas J, Vancsik, Tamás, Zolcsák, Zita, Benyó, Zoltán

“…Our objective was to develop an electromagnetic tumor therapy device in a consortial cooperation between Semmelweis University and Oncotherm Ltd., to provide…”
Get more information